Chang-Won Choi/Vice Chairman and CEO of SK Discovery
Mr. Chang-Won Choi has been leading SK Discovery, fostering growth in the energy, chemical, and bio industries. He played a key role in the development of South Korea's first COVID-19 vaccine, Skycovione, significantly contributing to the advancement of domestic vaccine development capabilities. Additionally, he has supported various educational and research institutions at his alma mater by donating scholarships, including to the "Happiness Research Center Academic Fund," demonstrating his dedication to nurturing future leaders.